Hamed Shahbazi
Founder, Chairman & CEO

Good morning, and welcome to the Annual General and Special Meeting of Shareholders of WELL Health Technologies Corp. My name is Hamed Shahbazi. I'm the Chairman of the company. And with your consent, I will serve as Chairman of today's meeting. Before we begin, I would like to remind shareholders that to the extent we make forward-looking statements about our business or prospects.

In the course of today's meeting, any such statements are based on management's beliefs and opinions and are subject to risks and uncertainties that may cause actual results to differ materially. Shareholders are encouraged to review our public disclosure documents available on SEDAR+, which contain detailed discussion of assumptions and risk factors.

I now ask that the Annual General and Special Meeting of the shareholders of the company come to order. We have 4 matters of formal business to conduct today: one, the presentation of our 2025 audited financial statements; two, the election of directors; three, the reappointment of Deloitte LLP Chartered Professional Accountants as auditors of the company; four, the reapproval of the company's Omnibus Equity Incentive Plan and unallocated entitlements thereunder.

Following the formal process, we will proceed with the corporate update and a question-and-answer period. Before we begin with the formal business of the meeting, we will go through the procedural matters. First, I appoint Eva Fong, Chief Financial Officer of the company as Secretary of the meeting.

I also appoint Pardeep Sangha, Investor Relations for the moderator of the virtual meeting. I appoint Dave Bains from Computershare as scrutineer of this meeting. And finally, I appoint Loreto Grimaldi, Chief